UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Cleveland-Cliffs
CLF
$7.02B
| $2.49M | ﹤0.01% |
165,221
+1,500
| +0.9% | +$25.4K |
|
1202
Sally Beauty Holdings
SBH
$1.58B
| $2.48M | ﹤0.01% |
98,846
-700
| -0.7% | -$18.1K |
|
|
URS
1203
DELISTED
URS CORP
URS
| $2.48M | ﹤0.01% |
54,066
| – | – |
|
|
KBIO
1204
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $2.47M | ﹤0.01% |
135,562
-2,711
| -2% | -$46.4K |
|
1205
Crocs
CROX
$6.77B
| $2.47M | ﹤0.01% |
164,399
+36,863
| +29% | +$549K |
|
|
BRCD
1206
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $2.47M | ﹤0.01% |
268,668
| – | – |
|
1207
Hexcel
HXL
$7.88B
| $2.47M | ﹤0.01% |
60,405
+1,100
| +2% | +$45.8K |
|
|
VR
1208
DELISTED
Validus Hold Ltd
VR
| $2.46M | ﹤0.01% |
64,458
+4,800
| +8% | +$179K |
|
1209
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $2.46M | ﹤0.01% |
37,145
+19,264
| +108% | +$1.25M |
|
1210
Cabot Corp
CBT
$4.23B
| $2.46M | ﹤0.01% |
42,423
+600
| +1% | +$35K |
|
|
INVX
1211
Innovex International
INVX
$2.21B
| $2.45M | ﹤0.01% |
22,409
+700
| +3% | +$75.2K |
|
1212
Maximus
MMS
$3.33B
| $2.44M | ﹤0.01% |
56,798
-41,400
| -42% | -$1.78M |
|
|
CST
1213
DELISTED
CST Brands, Inc.
CST
| $2.43M | ﹤0.01% |
70,501
+5,700
| +9% | +$185K |
|
|
CCG
1214
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
| $2.43M | ﹤0.01% |
280,817
-228
| -0.1% | -$1.99K |
|
1215
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.8B
| – | – |
0
| – | – |
|
1216
Leidos
LDOS
$16.4B
| $2.42M | ﹤0.01% |
63,176
-132,493
| -68% | -$5.02M |
|
1217
iShares Russell 2000 ETF
IWM
$83B
| $2.42M | ﹤0.01% |
20,344
-26,641
| -57% | -$3.03M |
|
|
ARRS
1218
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $2.4M | ﹤0.01% |
73,896
+13,100
| +22% | +$387K |
|
|
GRT
1219
DELISTED
GLIMCHER REALTY TRUST
GRT
| $2.4M | ﹤0.01% |
221,845
+5,300
| +2% | +$55.7K |
|
1220
Arista Networks
ANET
$240B
| $2.4M | ﹤0.01% |
+614,400
| New | +$2.47M |
|
1221
Teradyne
TER
$63.1B
| $2.38M | ﹤0.01% |
121,656
+700
| +0.6% | +$13K |
|
|
PAY
1222
DELISTED
Verifone Systems Inc
PAY
| $2.38M | ﹤0.01% |
64,622
+2,700
| +4% | +$92K |
|
|
OPLN
1223
Openlane
OPLN
$4.24B
| $2.36M | ﹤0.01% |
195,912
+792
| +0.4% | +$9.15K |
|
1224
CoStar Group
CSGP
$12.1B
| $2.36M | ﹤0.01% |
149,230
+22,840
| +18% | +$370K |
|
1225
Compañía de Cervecerías Unidas
CCU
$2.15B
| $2.34M | ﹤0.01% |
100,100
| – | – |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.